SEC Form 4 · accession 0001213900-17-008246
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nitya G. Ray
Officer — Executive Vice President
Period of report
Aug 2, 2017
Accepted (ET)
Aug 4, 2017 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 2, 2017 | P | 10,000 | $0.75 | A | 10,000 | D |
Table II — derivative securities
No Table II lines on this filing.